Regulation of Cardiomyocyte Maturation
Regulation of Cardiomyocyte Maturation
批准号:
10334508
负责人:
William Tswenching Pu
金额:
$58.88万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-03-15 至 2023-01-31
关键词:
AdultAnimalsCalciumCardiac MyocytesCardiac developmentCell CycleCell RespirationCell membraneCellsCharacteristicsChromatinCollectionComplexContractsDataDevelopmentDistalEnhancersEpigenetic ProcessGATA4 geneGenesGeneticGenetic ScreeningGenetic TranscriptionGoalsHeartHeart AbnormalitiesHeart DiseasesHeart failureHumanIntercellular JunctionsIon ChannelKnowledgeLifeMethodsMolecularMosaicismMusMutationMyocardialMyocardial dysfunctionNatural regenerationNuclear ReceptorsPatientsPerformancePerinatalPhenotypePhosphoric Monoester HydrolasesPhosphotransferasesPositioning AttributeProcessPumpRNA Polymerase IIReaderRegulationRoleSarcomeresShapesSignal PathwaySignaling MoleculeSignaling ProteinStressSurvivorsTAF1 geneTAF2 geneTAF3 geneTechniquesTestingTimecongenital heart disordercrystallinityembryonic stem cellfetalfrontiergene functionin vivoin vivo evaluationinnovationloss of functionmutantnovelnovel therapeuticspostnatalprogramspromoterstem cellssuccesstooltranscription factor
中文摘要
项目摘要/摘要
成年心肌细胞(CMS)专门用于在一年中收缩和松弛数十亿次
动物的一生。许多适应允许成年CMS履行这一角色,包括:大的,拉长的形状;
高度组织的细胞-细胞连接网络;对氧化代谢的依赖;近乎结晶的阵列
肌节.围绕质膜网络的钙释放单元的特征组织
T管内陷;细胞周期退出;成体CM特异性收缩钙的表达
操控和离子通道基因。在小鼠中,这些适应大多是在出生后的前三个月获得的
几周。对CM成熟程序的分子调控知之甚少。这种信息鸿沟
限制了刺激干细胞来源的CMS成熟的合理方法的发展。此外,它是
很可能是先天性心脏病突变或由先天性心脏病引起的异常心脏应激
畸形对心肌成熟的影响及其对先天性心肌长期表现的影响
心脏病患者。
我们的长期目标是了解管理CM成熟的监管计划。我们的
初步数据表明,GATA4和GATA6(GATA4/6)转录因子是CM的必需转录因子
成熟。此外,正向遗传筛查发现了RNA聚合酶II的一个组成部分TAF3
预启动复合体和阅读器H3K4me3的表观遗传标记,作为一种新的成熟调节因子。使用
许多独特和新颖的工具和方法,本提案将调查控制CM的机制
成熟。目标1将剖析GATA4和GATA6调节增强子活性的机制
Cm成熟。目标2将进一步描述TAF3突变体的特征,并剖析其调节机制
成熟。AIM 3将应用我们创新的体内正向遗传筛查来发现信号分子和
先天性心脏病基因是CM成熟所必需的。
胎儿CMS向成熟CMS的协调转换是最不好的之一
了解心脏发育的各个方面。成功实现该提案的目标将在以下方面提高我们的知识
这是心脏发育的未开发前沿。
英文摘要
Project Summary/Abstract
Adult cardiomyocytes (CMs) are specialized to forcefully contract and relax billions of times during an
animal's lifetime. A number of adaptations allow adult CMs to fulfill this role, including: large, elongated shape;
highly organized network of cell-cell junctions; reliance on oxidative metabolism; nearly crystalline array of
sarcomeres; characteristic organization of calcium release units around a network of plasma membrane
invaginations known as T-tubules; cell cycle exit; and expression of adult CM-specific contractile, calcium
handling, and ion channel genes. In mouse, most of these adaptations are acquired in the first three postnatal
weeks. Little is known about the molecular regulation of the CM maturation program. This information gap
limits development of rational approaches to stimulate maturation of stem-cell derived CMs. Furthermore, it is
likely that congenital heart disease mutations or abnormal cardiac stress caused by congenital heart
malformations impact CM maturation, with implications for long term myocardial performance of congenital
heart disease patients.
Our long term goal is to understand the regulatory program that governs CM maturation. Our
preliminary data show that GATA4 and GATA6 (GATA4/6) transcription factors are essential for CM
maturation. In addition, a forward genetic screen uncovered TAF3, a component of the RNA Polymerase II
pre-initiation complex and a reader of H3K4me3 epigenetic marks, as a novel maturation regulators. Using a
number of unique and novel tools and approaches, this proposal will investigate mechanisms that control CM
maturation. Aim 1 will dissect the mechanisms by which GATA4 and GATA6 regulate enhancer activity during
CM maturation. Aim 2 will further characterize TAF3 mutants and dissect the mechanisms by which it regulates
maturation. Aim 3 will apply our innovative in vivo forward genetic screen to discover signaling molecules and
congenital heart disease genes that are essential for CM maturation.
The coordinated transformation of fetal CMs to their mature counterparts is among the least well
understood aspects of cardiac development. Success with this proposal's aims will advance our knowledge in
this unexplored frontier of cardiac development.
期刊论文(8)
专著(0)
科研奖励(0)
会议论文
Molecule in mothers' milk nurses pups' heart cells to maturity.
母乳中的分子将幼崽的心脏细胞哺育至成熟。
DOI:
10.1038/d41586-023-01635-4
发表时间:
2023
期刊:
Nature
影响因子:
64.8
作者:
[Zhou,Pingzhu, Pu,WilliamT]
通讯作者:
Pu,WilliamT
DOI:
10.1007/s12551-020-00729-x
发表时间:
2020-08-01
期刊:
Biophysical reviews
影响因子:
--
作者:
[Lu, Fujian, Pu, William T]
通讯作者:
Pu, William T
A shared role of the myocardin-family transcriptional coactivators in cardiomyocyte maturation.
心肌素家族转录共激活因子在心肌细胞成熟中的共同作用。
DOI:
10.1007/s11427-023-2385-x
发表时间:
2023
期刊:
Science China. Life sciences
影响因子:
--
作者:
[Guo,Yuxuan, Cao,Yangpo, Jardin,BlakeD, Mazumdar,Neil, Guo,Congting, Yang,Luzi, Lin,Junsen, Chen,Zhan, Ma,Qing, Zhao,Mingming, Dong,Erdan, Pu,WilliamT]
通讯作者:
Pu,WilliamT
Desmosomes in cardiomyocyte homeostasis and disease
-
批准号:10606894
-
项目类别:
-
资助金额:$81.65万
-
财政年份:2022
-
负责人:William Tswenching Pu
-
依托单位:
CMYA5 regulation of cardiac dyad structure and function
-
批准号:10607816
-
项目类别:
-
资助金额:$61.46万
-
财政年份:2022
-
负责人:William Tswenching Pu
-
依托单位:
Genetic regulation of atrial gene expression in development and disease
-
批准号:10576399
-
项目类别:
-
资助金额:$60.73万
-
财政年份:2021
-
负责人:William Tswenching Pu
-
依托单位:
Genetic regulation of atrial gene expression in development and disease
-
批准号:10355481
-
项目类别:
-
资助金额:$60.73万
-
财政年份:2021
-
负责人:William Tswenching Pu
-
依托单位:
Regulation of Cardiomyocyte Maturation
-
批准号:9888413
-
项目类别:
-
资助金额:$58.88万
-
财政年份:2019
-
负责人:William Tswenching Pu
-
依托单位:
Enabling mammalian in vivo forward genetic screens based on cell morphology
-
批准号:9754850
-
项目类别:
-
资助金额:$21.01万
-
财政年份:2018
-
负责人:William Tswenching Pu
-
依托单位:
Transcriptional regulation of arteriovenous differentiation
-
批准号:9751955
-
项目类别:
-
资助金额:$54.98万
-
财政年份:2017
-
负责人:William Tswenching Pu
-
依托单位:
Transcriptional regulation of arteriovenous differentiation
-
批准号:9376461
-
项目类别:
-
资助金额:$52.34万
-
财政年份:2017
-
负责人:William Tswenching Pu
-
依托单位:
2015 Weinstein Cardiovaascular Development Conference
-
批准号:8911591
-
项目类别:
-
资助金额:$0.8万
-
财政年份:2015
-
负责人:William Tswenching Pu
-
依托单位:
YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration
-
批准号:8412652
-
项目类别:
-
资助金额:$56.5万
-
财政年份:2013
-
负责人:William Tswenching Pu
-
依托单位:
YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration
-
批准号:8606891
-
项目类别:
-
资助金额:$51.45万
-
财政年份:2013
-
负责人:William Tswenching Pu
-
依托单位:
YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration
-
批准号:8996701
-
项目类别:
-
资助金额:$52.5万
-
财政年份:2013
-
负责人:William Tswenching Pu
-
依托单位:
YAP1 Regulation of cardiomyocyte proliferation, function, and regeneration
-
批准号:9212191
-
项目类别:
-
资助金额:$52.5万
-
财政年份:2013
-
负责人:William Tswenching Pu
-
依托单位:
Regulation of Heart Function by a Gata4-Fog2 transcriptional complex
-
批准号:7783171
-
项目类别:
-
资助金额:$42.81万
-
财政年份:2010
-
负责人:William Tswenching Pu
-
依托单位:
Regulation of Heart Function by a Gata4-Fog2 transcriptional complex
-
批准号:8206596
-
项目类别:
-
资助金额:$43.5万
-
财政年份:2010
-
负责人:William Tswenching Pu
-
依托单位:
Regulation of Heart Function by a Gata4-Fog2 transcriptional complex
-
批准号:8391704
-
项目类别:
-
资助金额:$41.41万
-
财政年份:2010
-
负责人:William Tswenching Pu
-
依托单位:
Regulation of Heart Function by a Gata4-Fog2 transcriptional complex
-
批准号:8013611
-
项目类别:
-
资助金额:$43.13万
-
财政年份:2010
-
负责人:William Tswenching Pu
-
依托单位:
Epicardial progenitors in the developing and postnatal heart
-
批准号:8704989
-
项目类别:
-
资助金额:$43.91万
-
财政年份:2009
-
负责人:William Tswenching Pu
-
依托单位:
Epicardial progenitors in the developing and postnatal heart
-
批准号:8898180
-
项目类别:
-
资助金额:$44.13万
-
财政年份:2009
-
负责人:William Tswenching Pu
-
依托单位:
Epicardial progenitors in the developing and postnatal heart
-
批准号:9099870
-
项目类别:
-
资助金额:$44.8万
-
财政年份:2009
-
负责人:William Tswenching Pu
-
依托单位:
海外基金